- Raffles Medical’s Chinese hospitals are facing a surge in COVID-19 patients due to the relaxation of China’s nationwide restrictions. For its Singapore hospitals, foreign patient levels have recovered close to pre-COVID-19 levels, driven mostly by patients from Indonesia and Southeast Asia.
- - Read this at SGinvestors.io -
No more Zero-COVID for China
- China ended most of its nationwide Zero-COVID policies in a bid to boost its economy and transition into COVID-19 endemicity. After three years of self-isolation and strict lockdowns, China lifted domestic quarantine restrictions as well as relaxed domestic and foreign travel guidelines, whereby inbound travellers are now able to enter the country quarantine-free.
- - Read this at SGinvestors.io -
Mixed bag.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
Llelleythan Tan UOB Kay Hian Research | John Cheong UOB Kay Hian | https://research.uobkayhian.com/ 2023-01-16
Read also UOB's most recent report:
2024-07-30 Raffles Medical - 1H24 Results Slightly Below Expectations, Margins Remain Soft.
Previous report by UOB:
2024-02-27 Raffles Medical - Weaker 2023 Margins In Line With Expectations; Headwinds Persist.
Price targets by other brokers at Raffles Medical Target Prices.
Listing of research reports at Raffles Medical Analyst Reports.
Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividends & Corporate Actions,
Raffles Medical News Articles
